107 related articles for article (PubMed ID: 9334823)
1. Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met.
Corps AN; Sowter HM; Smith SK
Int J Cancer; 1997 Sep; 73(1):151-5. PubMed ID: 9334823
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells.
Sowter HM; Corps AN; Smith SK
Int J Cancer; 1999 Nov; 83(4):476-80. PubMed ID: 10508482
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor.
Klominek J; Baskin B; Liu Z; Hauzenberger D
Int J Cancer; 1998 Apr; 76(2):240-9. PubMed ID: 9537587
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway.
Ueoka Y; Kato K; Wake N
Mol Cell Endocrinol; 2003 Apr; 202(1-2):81-8. PubMed ID: 12770735
[TBL] [Abstract][Full Text] [Related]
5. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
Chen Q; DeFrances MC; Zarnegar R
Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
[TBL] [Abstract][Full Text] [Related]
6. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells.
Welch WC; Kornblith PL; Michalopoulos GK; Petersen BE; Beedle A; Gollin SM; Goldfarb RH
Anticancer Res; 1999; 19(3A):1635-40. PubMed ID: 10470094
[TBL] [Abstract][Full Text] [Related]
8. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor induces rat ovarian surface epithelial cell mitosis or apoptosis depending on the presence or absence of an extracellular matrix.
Hess S; Gulati R; Peluso JJ
Endocrinology; 1999 Jun; 140(6):2908-16. PubMed ID: 10342884
[TBL] [Abstract][Full Text] [Related]
10. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells.
Wong AS; Leung PC; Auersperg N
Gynecol Oncol; 2000 Aug; 78(2):158-65. PubMed ID: 10926796
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
Rubin JS; Day RM; Breckenridge D; Atabey N; Taylor WG; Stahl SJ; Wingfield PT; Kaufman JD; Schwall R; Bottaro DP
J Biol Chem; 2001 Aug; 276(35):32977-83. PubMed ID: 11435444
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor stimulates the growth and activates mitogen-activated protein kinase in human hepatoma cells.
Lee HS; Huang AM; Huang GT; Yang PM; Chen PJ; Sheu JC; Lai MY; Lee SC; Chou CK; Chen DS
J Biomed Sci; 1998; 5(3):180-4. PubMed ID: 9678488
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a functional HGF/C-MET autocrine loop in spontaneous transformants of WB-F344 rat liver stem-like cells.
Presnell SC; Hooth MJ; Borchert KM; Coleman WB; Grisham JW; Smith GJ
Hepatology; 1998 Nov; 28(5):1253-9. PubMed ID: 9794909
[TBL] [Abstract][Full Text] [Related]
16. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
18. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
[TBL] [Abstract][Full Text] [Related]
20. Met overexpression confers HGF-dependent invasive phenotype to human thyroid carcinoma cells in vitro.
de Luca A; Arena N; Sena LM; Medico E
J Cell Physiol; 1999 Sep; 180(3):365-71. PubMed ID: 10430176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
